ArticleCardiovascular drugs and therapy2025

Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.

Evelyn Krohmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.